I want more information

    What is ThyroidPrint?

    A test that avoids unnecessary thyroid surgeries

    If you have been diagnosed with an indeterminate thyroid nodule (Bethesda III or IV), your risk of cancer ranges between 15 to 30%. If your ThyroidPrint test result is benign the risk of cancer of your nodule falls to less than 5% and you can forgo a diagnostic surgery.

    Play Video

    ThyroidPrint in numbers

    Tests performed
    + 0
    Available in 0 Countries
    Surgeries avoided
    + 0 %
    Years of research
    + 0

    Centers working with us


    ThyroidPrint, available worldwide to improve your quality of life

    ThyroidPrint is a test clinically validated in the United States and Latin America, developed by GeneproDX. Our mission is to change how indeterminate thyroid nodules are diagnosed and treated worldwide.

    What do

    our patients say?

    Play Video
    Testimonial Ximena Urzua
    Play Video
    Testimonial Macarena Bustamante
    Play Video
    Testimonial María Sonia Herrera

    Authorizations and accreditations

    Our clinical laboratory is CAP-accredited (College of American Pathologists), which is the highest standard accreditation for clinical laboratories worldwide.